Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News
Thrombectomy access lags for U.S. stroke patients
In 2017, 20% of U.S. acute ischemic stroke patients were within 15 minutes of an endovascular thrombectomy-capable stroke center.
News
Statin, antihypertensive treatment don’t guarantee healthier lifestyles
Data from 41,000 Finns showed that people put on a primary CVD-prevention regimen don’t always turn healthier.
News
Heart rhythm data from wearables confounds EP practice
NATIONAL HARBOR, MD. – Cardiac electrophysiologists increasingly see patients who’ve received arrhythmia alerts from wearable devices.
News
Vigilance safely keeps AFib patients off anticoagulants post ablation
NATIONAL HARBOR, MD. – One U.S. center uses frequent monitoring to allow selected AFib patients to safely stop anticoagulation after catheter...
News
Score predicts surgery’s benefits for obesity, diabetes
†obesity
LAS VEGAS –
News
Catheter cryoablation effective for persistent AFib in pivotal trial
NATIONAL HARBOR, MD. – Cryoballoon becomes the first catheter ablating device to show efficacy and safety for persistent AFib in an FDA-approved...
News
AFib link with titin mutations warrants selected genetic testing
Evidence strongly links loss-of-function mutations in the titin gene with AFib, and patients are now seeking genetic testing.
News
FDA advisers set high bar for new opioids
Two days of FDA discussion over three new opioids seeking U.S. approval highlighted the barriers these drugs now face.
News
Coronary function testing during angiography boosts 1-year angina outcomes
PHILADELPHIA – Diagnosing coronary microvascular disease or vasospasm during angiography improved angina outcomes; new findings help show why.
News
FDA committee rejects oxycodegol, new opioid designed for less abuse
A novel opioid molecule designed to have less abuse potential with slower CNS entry received a unanimous FDA committee turn down.
News
Half of SLE patients have incident neuropsychiatric events
Average 8-year follow-up of an international lupus inception cohort showed that 52% developed a neuropsychiatric event.
News
Diabetes boosts bariatric surgery complications
LAS VEGAS – In addition, patients with insulin-dependent diabetes had significantly higher rates of these and other complications, compared with...
